WCN26-5301 ICODEXTRIN USE IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK IN PERITONEAL DIALYSIS PATIENTS: A COMPETING RISK ANALYSIS

Read full text Summarise with VIRAT
Authors: Naohiro Muraki, Naoto Hamano, Go Shimada, Daiki Matsumoto, Ryohei Inanaga, Katsuomi Matsui, Michiya Shinozaki
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Icodextrin (Ico) is a key osmotic agent for managing fluid overload in peritoneal dialysis (PD) patients, which is expected to reduce heart failure risk. However, its association with overall cardiovascular (CV) risk remains controversial. Ico solutions contain 3.5 mEq/L of calcium, which may lead to a positive calcium balance if peritoneal convection is insufficient. We hypothesized that the use of Ico is associated with an increased risk of CV events, potentially mediated by an increased calcium load.

Fields of Study & Subjects

Dialysis and Renal Disease Management Parathyroid Disorders and Treatments Heart Failure Treatment and Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105892–105892
Publication date
25 March 2026
Language
EN